Oncolytics Biotech, Inc. (ONCY)
1.05
-0.01
(-0.94%)
USD |
NASDAQ |
Mar 05, 13:14
Oncolytics Biotech EPS Diluted (Quarterly) : -0.1032 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
| ProMIS Neurosciences, Inc. | -5.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.46M |
| Total Expenses (Quarterly) | 10.46M |
| Enterprise Value | 105.79M |
| Earnings Yield | -26.76% |
| Normalized Earnings Yield | -26.23 |